Squamous Cell HN009

Study #HN009

Randomized Phase II/III Trial of Radiation with High-Dose Cisplatin (100 mg/m²) Every Three Weeks Versus Radiation with Low-Dose Weekly Cisplatin (40 mg/m²) for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)